WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010122091) THIA-TRIAZA-AS-INDACENES AS PI3-KINASES INHIBITORS FOR THE TREATMENT OF CANCER
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/122091    International Application No.:    PCT/EP2010/055321
Publication Date: 28.10.2010 International Filing Date: 22.04.2010
IPC:
C07D 513/04 (2006.01), C07D 513/14 (2006.01), A61K 31/4439 (2006.01), A61P 35/00 (2006.01)
Applicants: BOEHRINGER INGELHEIM INTERNATIONAL GMBH [DE/DE]; Binger Strasse 173 55216 Ingelheim Am Rhein (DE) (For All Designated States Except US).
VAN DER VEEN, Lars [NL/DE]; (DE) (For US Only).
MC CONNELL, Darryl [AU/DE]; (DE) (For US Only).
SCHNEIDER, Siegfried [DE/DE]; (DE) (For US Only).
GRAUERT, Matthias [DE/DE]; (DE) (For US Only).
SCHOOP, Andreas [DE/DE]; (DE) (For US Only).
WUNBERG, Tobias [DE/DE]; (DE) (For US Only)
Inventors: VAN DER VEEN, Lars; (DE).
MC CONNELL, Darryl; (DE).
SCHNEIDER, Siegfried; (DE).
GRAUERT, Matthias; (DE).
SCHOOP, Andreas; (DE).
WUNBERG, Tobias; (DE)
Agent: HAMMANN, Heinz, et al.; Boehringer Ingelheim Gmbh Patents Germany Binger Strasse 173 55216 Ingelheim Am Rhein (DE)
Priority Data:
09158494.6 22.04.2009 EP
Title (EN) THIA-TRIAZA-AS-INDACENES AS PI3-KINASES INHIBITORS FOR THE TREATMENT OF CANCER
(FR) THIA-TRIAZA-AS-INDACÈNES EN TANT QU'INHIBITEURS DES PI3 KINASES POUR LE TRAITEMENT DU CANCER
Abstract: front page image
(EN)The present invention encompasses compounds of general formula (1) wherein R1 to R3 and X are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
(FR)La présente invention englobe des composés de formule générale (1) où R1 à R3 et X sont tels que définis dans la revendication 1, qui sont appropriés pour le traitement de maladies caractérisées par une prolifération cellulaire excessive ou anormale, et sur leur utilisation pour la préparation d'un médicament ayant les propriétés mentionnées ci-dessus.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)